心血管疾病中的AXL:病理生理学见解和临床观点
Cheng Qian1, Chao Wang1, Fang Liu1
1International Genome Center, Jiangsu University, Zhenjiang 212013, China.
Pathology, research and practice
|July 13, 2025
概括
心血管疾病 (CVD) 是一个主要的全球健康问题. AXL受体氨酸激酶在心血管疾病中起着复杂的双重作用,提供潜在的治疗点,但需要谨慎的,特定于环境的策略.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 受体氨酸激酶信号传递受体
背景情况:
- 心血管疾病 (CVD) 是全球死亡的主要原因.
- 作为TAM家族成员的AXL受体氨酸激酶,涉及到心血管疾病的发病.
- 在心血管系统中,AXL具有多方面的作用.
研究的目的:
- 综合审查心血管系统中AXL的生物功能.
- 为了强调AXL在调节心血管过程中的二元性.
- 探索在心血管疾病中准AXL的治疗潜力.
主要方法:
- 对AXL在心血管病理学中的作用的文献综述.
- 对AXL对各种心血管细胞类型的情境依赖性影响的分析.
- 检查AXL介导的信号通路,包括GAS6/AXL.
主要成果:
- AXL影响着亡,炎症,氧化应激和血管重塑.
- 在内皮细胞,光滑肌细胞,巨细胞和心肌细胞中,AXL具有上下文依赖的作用.
- 在诸如动脉样硬化和缺血-再输液损伤等疾病中,AXL信号可以是保护性的或有害的.
结论:
- AXL在心血管健康和疾病中的作用是复杂的,并且取决于背景.
- 准AXL对心血管疾病具有治疗潜力.
- 开发特定于细胞类型和情境敏感的AXL干预措施至关重要.
相关概念视频
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
47
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
47
Coronary Artery Disease II: Pathophysiology
40
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
40
Coronary Artery Disease I: Introduction
60
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
60
Atherosclerosis III: Management
40
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
40
Cardiovascular Drugs: Classification based on Therapeutic Indications
3.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.2K
Heart Failure II: Pathophysiology
46
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
46


